Fundraising through a Third-Party Allotment of New Shares and Stock Acquisition Rights
First written in FY2022-Q1. 10 of 12 entries say "Advanced", first in FY2022. Latest entry: FY2026.
11 other companies' latest entry also says "Advanced".
- FY2026AdvancedAnnual report
「1 April 2025–31 March 2026 (Note) 1 10,000 30,318,000 1,325 3,149,715 1,325 3,050,514」
The exercise of stock acquisition rights resulted in the issuance of 10,000 shares and an increase of ¥1,325 thousand each in stated capital and capital reserves. - FY2026-H1No exercise of stock acquisition rights or share issuanceAnnual report
「1 April 2025–30 September 2025 - 30,308,000 - 3,148,390 - 3,049,189」
During the current interim consolidated accounting period, there were no changes in the total number of shares issued, stated capital or capital reserves, and no new financing through the exercise of stock acquisition rights or other means was disclosed. - FY2025AdvancedAnnual report
「1 April 2024–31 March 2025 (Note) 1 55,000 30,308,000 7,287 3,148,390 7,287 3,049,189 (Note) 1. Increase due to the exercise of stock acquisition rights.」
The Company issued 55,000 shares through the exercise of stock acquisition rights, increasing stated capital and capital reserves by ¥7,287 thousand each. - FY2025-H1AdvancedAnnual report
「1 April 2024–30 September 2024 (Note) 55,000 30,308,000 7,287 3,148,390 7,287 3,049,189 (Note) Increase resulting from the exercise of stock acquisition rights.」
During the current interim accounting period, 55,000 shares were issued through the exercise of stock acquisition rights, increasing stated capital and capital reserves by ¥7,287 thousand each. - FY2024AdvancedAnnual report
「1 April 2023–31 March 2024 (Note) 1, 3 177,600 30,253,000 23,532 3,141,103 23,532 3,041,902」
The Company raised additional funds through the issuance of 177,600 shares upon the exercise of stock acquisition rights, increasing stated capital and capital reserves by ¥23,532 thousand each. - FY2024-Q3AdvancedAnnual report
「1 October 2023–31 December 2023 (Note) 12,000 30,146,400 1,590 3,126,978 1,590 3,027,777 (Note) Increase resulting from the exercise of stock acquisition rights.」
During the third quarter, 12,000 shares were issued through the exercise of stock acquisition rights, increasing stated capital and capital reserves by ¥1,590 thousand each. - FY2024-Q2AdvancedAnnual report
「Proceeds from the issuance of shares through the exercise of stock acquisition rights 15,175」
The Company raised ¥15 million through the exercise of stock acquisition rights, and financing through the third-party allotment and stock acquisition rights continued to be executed. - FY2023AdvancedAnnual report
「During the current consolidated fiscal year, the Company raised ¥400 million in long-term borrowings from financial institutions in preparation for the spread and prolonged duration of COVID-19. It also raised ¥1,646 million through a third-party allotment and ¥8 million through the issuance of stock acquisition rights.」
During the current fiscal year, following financing through the third-party allotment and stock acquisition rights, the Company raised ¥1,932 million through the issuance of 3,033,000 shares upon the exercise of stock acquisition rights. - FY2023-Q3AdvancedAnnual report
「As a result of an increase of ¥972,040 thousand in stated capital and ¥968,839 thousand in capital reserves, among other factors, through the exercise of the First and Second Series of Stock Acquisition Rights of 2021 issued on 30 May 2021, stated capital was ¥3,115,981 thousand and capital surplus was ¥2,947,009 thousand at the end of the third quarter of the current consolidated fiscal year.」
The exercise of stock acquisition rights increased stated capital by ¥972,040 thousand and capital reserves by ¥968,839 thousand, resulting in further financing. - FY2023-Q2AdvancedAnnual report
「Proceeds from the issuance of shares through the exercise of stock acquisition rights 1,013,499」
The Company raised ¥1,013 million through the exercise of stock acquisition rights, and financing through the third-party allotment and stock acquisition rights progressed to the execution stage. - FY2022AdvancedAnnual report
「During the current consolidated fiscal year, the Company raised ¥400 million in long-term borrowings from financial institutions in preparation for the spread and prolonged duration of COVID-19. It also raised ¥1,646 million through a third-party allotment and ¥8 million through the issuance of stock acquisition rights.」
As a precaution against the prolonged pandemic, the Company raised ¥400 million in long-term borrowings, ¥1,646 million through a third-party allotment and ¥8 million through the issuance of stock acquisition rights. - FY2022-Q1First statedAnnual report
「At its meeting on 14 May 2021, the Company’s Board of Directors resolved to issue new shares through a third-party allotment, as well as the First Series and Second Series of Stock Acquisition Rights of 2021. Payment of ¥1,646 million for the new share issue and ¥8 million for the issuance of the First and Second Series of Stock Acquisition Rights of 2021 was completed on 31 May 2021.」
As a measure to address the prolonged pandemic, the Company resolved to issue new shares through a third-party allotment and 2 types of stock acquisition rights, and completed payment of a total of ¥1,654 million.